000 | 01925 a2200565 4500 | ||
---|---|---|---|
005 | 20250517191525.0 | ||
264 | 0 | _c20190813 | |
008 | 201908s 0 0 eng d | ||
022 | _a1524-4571 | ||
024 | 7 |
_a10.1161/CIRCRESAHA.117.312380 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGood, Miranda E | |
245 | 0 | 0 |
_aPannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone. _h[electronic resource] |
260 |
_bCirculation research _c02 2018 |
||
300 |
_a606-615 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aArterioles _xdrug effects |
650 | 0 | 4 |
_aConnexins _xantagonists & inhibitors |
650 | 0 | 4 |
_aDiuretics _xpharmacology |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aJurkat Cells |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xpharmacology |
650 | 0 | 4 |
_aNerve Tissue Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aSpironolactone _xpharmacology |
700 | 1 | _aChiu, Yu-Hsin | |
700 | 1 | _aPoon, Ivan K H | |
700 | 1 | _aMedina, Christopher B | |
700 | 1 | _aButcher, Joshua T | |
700 | 1 | _aMendu, Suresh K | |
700 | 1 | _aDeLalio, Leon J | |
700 | 1 | _aLohman, Alexander W | |
700 | 1 | _aLeitinger, Norbert | |
700 | 1 | _aBarrett, Eugene | |
700 | 1 | _aLorenz, Ulrike M | |
700 | 1 | _aDesai, Bimal N | |
700 | 1 | _aJaffe, Iris Z | |
700 | 1 | _aBayliss, Douglas A | |
700 | 1 | _aIsakson, Brant E | |
700 | 1 | _aRavichandran, Kodi S | |
773 | 0 |
_tCirculation research _gvol. 122 _gno. 4 _gp. 606-615 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCRESAHA.117.312380 _zAvailable from publisher's website |
999 |
_c27886163 _d27886163 |